Tenet Healthcare (THC) Tops Q4 EPS by 1c; Provides Wide EPS Guidance

Tenet Healthcare (NYSE: THC) reported Q4 EPS of $0.35, $0.01 better than the analyst estimate of $0.34. Revenue for the quarter came in at $5.03 billion versus the consensus estimate of $4.82 billion.

GUIDANCE:

Tenet Healthcare sees Q1 2016 EPS of $0.05-$0.54, versus the consensus of $0.56. Tenet Healthcare sees Q1 2016 revenue of $4.7-4.9 billion, versus the consensus of $4.72 billion.

Tenet Healthcare sees FY2016 EPS of $1.18-$2.25, versus the consensus of $2.15. Tenet Healthcare sees FY2016 revenue of $18.8-19.2 billion, versus the consensus of $19.1 billion.

"We delivered Adjusted EBITDA at the midpoint of our Outlook for the fourth quarter and are on a path to deliver strong growth in Adjusted EBITDA and improved Adjusted Free Cash Flow in 2016,” said Trevor Fetter, chairman and chief executive officer. “Similar to our results in the third quarter, we experienced pressure on lower acuity inpatient hospital admissions and continued to drive increases in higher-acuity admissions. Our Conifer Health Solutions and United Surgical Partners subsidiaries performed well, with Conifer meeting our expectations and USPI delivering stronger-than-expected results in the fourth quarter.”

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
• Mizuho Reiterates Outperform Rating on Gulfport Energy (GPOR)
• Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance